Technology
Our brain biomarker discovery platform
By merging neuroscience with advanced data analytics powered by machine learning, we are developing paradigm-shifting technology for precision patient care and precision drug development.
Neumarker’s technology is built on the foundational principle that “neurons that fire together, wire together.” Our innovative approach leverages simple electroencephalogram (EEG) measurements, combined with our patented machine learning technologies, to uncover diagnostic and treatment outcome prediction biomarkers that are crucial for understanding and addressing CNS diseases. Our versatile platform has the potential to be applied to a wide range of debilitating conditions, including major depression, anxiety, bipolar disorder, schizophrenia, ADHD, autism, epilepsy, and Alzheimer’s disease.
Our machine learning models, rigorously tested and validated across multiple clinical datasets, are robust and dependable tools. They have the potential to reduce ineffective treatments by up to 50% and enhance clinical trial effect sizes by as much as threefold.
Key Facts and Figures
3x
Improvement of effect size
50%
Reduction of ineffective treatments
10
Patent applications
Applications of our biomarker platform
Neumarker’s core business is centered on individual patient treatment decision support services to hospitals and clinicians. We have established partnerships with leading entities, including some of the largest integrated hospital groups. Key benefits of the Neumarker platform include the ability to:
- Increase Patient Satisfaction: Ensuring better adherence and retention in treatment plans
- Tailor Treatment Plans: Personalized strategies based on patient-specific data.
- Reduce Trial-and-Error: Accelerating recovery by minimizing time spent on ineffective treatments.
- Enhance Outcomes: Leveraging precision psychiatry to improve patient health.
Additionally, Neumarker offers patient screening services to enhance the efficiency and efficacy of clinical trials for pharmaceutical, biotech and medical device companies. We are working with several top pharmaceutical companies and numerous biotech firms at various partnership stages. Our valuable clinical trial support service can:
- Speed up time to market
- Facilitate early phase decisions in clinical trials
- Identify target symptoms and differentiation strategies
- Reduce clinical trial failure rate by reducing heterogeneity of patients
- Reduce patient sample size, clinical trial time and cost
Neumarker 